Annals of Oncology

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2024
June 2024
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930

Annals of Oncology
May 24, 2024, 11:17 | Insight
Piotr Wysocki: Patients with hypermutated colorectal cancer (POLE/D1pd) derive profound benefit from immunotherapy
Piotr Wysocki recently posted on LinkedIn: "Ambrosini N et al. published online (Annals of Oncology) the…
May 14, 2024, 14:59 | Blog
Annals of Oncology March 2024 issue article of the month
Annals of Oncology shared a post by Annals of Oncology on X/Twitter, adding: ''The article…
May 13, 2024, 07:59 | Blog
Erika Hamilton: Check out our new practice LinkedIn page
Erika Hamilton shared a post by SCRI Oncology Partners on LinkedIn, adding: ''Check out our new practice…
May 12, 2024, 14:34 | Societies
Tom Powles talks to Amanda Psyrri about immune cell-related biomarkers in HNSCC - ESMO
ESMO - European Society for Medical Oncology shared on LinkedIn: “Latest podcast Annals of Oncology…
May 9, 2024, 11:35 | Insight
Vivek Subbiah: SERENA-1 monotherapy results in Annals of Oncology
Quoting Vivek Subbiah on X: . "A Phase 1 dose escalation and expansion trial of…
Apr 23, 2024, 20:12 | Blog
Antonio Passaro: An honor to have been a part of this significant manuscript, just out in Annals of Oncology driving forward the clinical development of ADCs
Antonio Passaro, Medical Director with Highly Specialized Position at IEO European Institute of Oncology, shared on…
Apr 23, 2024, 11:38 | Insight
Antonio Passaro: ETOP IBCSG Partners Foundation's position statement on antibody-drug conjugates (ADC) in lung and breast cancer
Antonio Passaro, Lung cancer Oncologist and Researcher at IEO, recently shared on X: "Just out…
Apr 22, 2024, 19:23 | Insight
New Paper Alert! A Comprehensive Review of ADCs in Lung and Breast Cancer by the ETOP IBCSG Partners Foundation
A Comprehensive Review of ADCs in Lung and Breast Cancer by the ETOP IBCSG Partners…
Apr 15, 2024, 17:01 | Drugs
Elisa Agostinetto: It’s likely that adjuvant Pembrolizumab has a lower impact compared to neoadjuvant Pembrolizumab
Elisa Agostinetto, Research Physician at the Institute of Jules Bordet in Brussels, posted on X/Twitter:…
Apr 12, 2024, 09:26 | Insight
In this Letter to the Editor, the Cancer Immunotherapy AEs Working Group details the pitfalls of reporting in immunotherapy clinical trials - Annals of Oncology
Annals of Oncology shared a post on X: "Immune checkpoint inhibitors are now standard-of -care in…
All: 32 Posts: 11 - 20